Doctors are calling on men to who are hospitalized with lung showing low testosterone levels in males predispose them to severe COVID-19 coronavirus symptoms if they should become ill with a respiratory infection. A study published in THE AGING MALE says men with low testosterone levels are also more prone to die from influenza as well.
The critical situation posed by the COVID-19 coronavirus among high-risk individuals and the vulnerability of the earth's 7.9 billion human population to a newly mutated COVID-19 coronavirus without a proven vaccine has prompted Moshe Shifrine PhD to pose a revolutionary therapy based upon his decades of research in the field of olfactory (smell) therapy.
Dr. Shifrine holds two patents on the use of odors to tickle the olfactory bulb in the nose to produce hormones like testosterone and insulin. Dr. Shifrine writes:
"Just a small number of molecules (in a concentration in billionths of a gram) in the nasal passages are needed to carry scent to the 20,000 nerve receptors in the olfactory bulb that is located on both hemispheres of the forebrain. When the molecules attach to these receptors their vibratory signature sends an electric signal to the hypothalamus in the brain that results in the production of the smelled substance. For example, the scent of testosterone or insulin stimulates the body's production of these hormones."
Dr. Shifrine instructs: The olfactory system is able to distinguish 12,000 different aromas.
Dr. Shifrine holds a patent (US 8,679,507 B2) for the use of truffle extract that contains a very small amount of natural testosterone. A whiff of same has been demonstrated to double testosterone levels in men in all ten subjects tested. The truffle extract, available commercially, also elevates testosterone levels in females and was demonstrated to alleviate common symptoms of menopause.
Use of a patient's own antibodies
Shifrine, who has spent 15 years investigating olfactory science, suggests, via a natural mechanism he calls HARMONIC OLFACTORY IMMUNITY. Instead of using truffle extract it may even be possible to use a patient's own natural antibodies obtained from saliva via a mouth swab and expose the olfactory bulb to them in the nasal passages. This in turn would make direct contact with the brain and therefore would purportedly increase antibody response throughout the body.
The thymus gland, where T-memory cells are made to produce life-long immunity, is under control of the hypothalamus in the brain, so this is not a far-fetched idea. Surgical removal of the pituitary gland, which is under control of the hypothalamus, results in thymus gland atrophy (shrinkage).
While this specific effect hasn't been put to the test yet, says Dr. Shifrine, given the present desperate circumstances with no antibody provoking vaccine in place, he asks health practitioners treating COVID-19 coronavirus infected patients to begin exposing the olfactory system to COVID-19 coronavirus antibodies when they obtain mouth swabs for antibody testing. Then conduct before-and-after tests to see if there is an antibody-boosting effect. The presumption is that infected patients are already producing antibodies, but maybe just not enough. It's kind of like a vaccine booster shot.